Comparative Benchmarking
In the context of the broader market, KALA competes directly with industry leaders such as PBYI and ACRS. With a market capitalization of $346.31M, it holds a leading position in the sector. When comparing efficiency, KALA's gross margin of N/A stands against PBYI's 69.35% and ACRS's -13.44%. Such benchmarking helps identify whether KALA BIO Inc is trading at a premium or discount relative to its financial performance.
